| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 6 | |
| #2 | WIPO (World Intellectual Property Organization) | 6 | |
| #3 | United States | 3 | |
| #4 | Australia | 2 | |
| #5 | China | 2 | |
| #6 | Brazil | 1 | |
| #7 | Canada | 1 | |
| #8 | Israel | 1 | |
| #9 | Japan | 1 | |
| #10 | Republic of Korea | 1 | |
| #11 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry | |
| #4 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Acyclic or carbocyclic compounds | |
| #5 | Climate change adaptation technologies | |
| #6 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Zeng Weiguang | 19 |
| #2 | Demaison Christophe | 18 |
| #3 | Jackson David | 16 |
| #4 | Holmes Ian | 14 |
| #5 | Bartlett Nathan | 5 |
| #6 | Girkin Jason | 5 |
| #7 | Jackson David Charles | 5 |
| #8 | Tan Amabel | 5 |
| #9 | Mercuri Francesca | 4 |
| #10 | Wong Chinn Yi | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021042171A1 | Cancer immunotherapy | |
| WO2021042174A1 | Cancer treatment | |
| WO2020257870A1 | Novel molecules | |
| KR20200101428A | Optimized compound | |
| EP3727372A1 | Administration of a tlr2 agonist for the treatment or prevention of a respiratory condition associated with an infectious agent | |
| CN110461351A | With TLR2 agonist treatment respiratory tract infection |